Showing results (1-10 of 388) with videos related to
Sort By:
Pageof 39
Expert Opinion on Therapeutic Patents|April 5, 2011
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010)Peng Zhan, Xinyong LiuCurrent Pharmaceutical Design|June 13, 2009
Designed multiple ligands: an emerging anti-HIV drug discovery paradigmPeng Zhan, Xinyong LiuMini Reviews in Medicinal Chemistry|April 23, 2010
Naturally occurring and synthetic bioactive molecules as novel non-nucleoside HBV inhibitorsPeng Zhan, Xuemei Jiang, Xinyong LiuCurrent Pharmaceutical Design|July 18, 2013
Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activitiesYu'ning Song, Peng Zhan, Xinyong LiuAngewandte Chemie (International Ed. in English)|April 12, 2021
Chiral Metal Nanoparticle Superlattices Enabled by Porphyrin-Based Supramolecular StructuresFei Yang, Xinyong Liu, Zhijie YangMini Reviews in Medicinal Chemistry|June 15, 2010
Cosalane and its analogues: a unique class of anti-HIV agentsPeng Zhan, Zhenyu Li, Xinyong LiuCurrent Medicinal Chemistry|August 20, 2009
Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006-2008 updatePeng Zhan, Xinyong Liu, Zhenyu LiJournal of Medicinal Chemistry|March 28, 2019
Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candidate with Reduced Metabolic LiabilityPeng Zhan, Dongwei Kang, Xinyong LiuInternational Journal of Biological Macromolecules|January 19, 2025
A type of cryptic epitope-binding antibody on SARS-CoV-2 RBD retains the neutralization against SARS-CoV-2 variants and sarbecovirusesWeiwei Zou, Zeshuai Zhang, Xinyong LiuInternational Journal of Molecular Sciences|July 13, 2024
Antiviral Drug DiscoveryZhenzhen Zhou, Xinyong Liu, Dongwei KangPageof 39